Piper Sandler Companies (NYSE:PIPR – Get Free Report) is set to issue its quarterly earnings data before the market opens on Friday, October 25th. Analysts expect Piper Sandler Companies to post earnings of $2.53 per share for the quarter.
Piper Sandler Companies (NYSE:PIPR – Get Free Report) last released its earnings results on Friday, August 2nd. The financial services provider reported $2.52 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.26 by $0.26. Piper Sandler Companies had a return on equity of 15.36% and a net margin of 9.23%. The firm had revenue of $357.00 million for the quarter, compared to the consensus estimate of $338.90 million. During the same period in the prior year, the firm earned $1.13 EPS. The firm’s revenue was up 23.7% on a year-over-year basis. On average, analysts expect Piper Sandler Companies to post $12 EPS for the current fiscal year and $15 EPS for the next fiscal year.
Piper Sandler Companies Price Performance
PIPR traded down $2.23 on Friday, reaching $301.39. 4,914 shares of the stock were exchanged, compared to its average volume of 106,434. The company’s 50-day moving average price is $285.60 and its 200 day moving average price is $269.42. The firm has a market capitalization of $5.33 billion, a PE ratio of 51.47 and a beta of 1.39. Piper Sandler Companies has a fifty-two week low of $130.89 and a fifty-two week high of $305.54.
Piper Sandler Companies Increases Dividend
Analyst Upgrades and Downgrades
Separately, JMP Securities reaffirmed a “market perform” rating on shares of Piper Sandler Companies in a report on Tuesday, September 17th.
Check Out Our Latest Report on PIPR
Insider Activity
In other Piper Sandler Companies news, Director Philip Soran sold 1,792 shares of the business’s stock in a transaction that occurred on Wednesday, August 21st. The stock was sold at an average price of $263.92, for a total value of $472,944.64. Following the completion of the transaction, the director now directly owns 18,341 shares of the company’s stock, valued at approximately $4,840,556.72. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. In related news, Director Philip Soran sold 1,792 shares of the firm’s stock in a transaction on Wednesday, August 21st. The shares were sold at an average price of $263.92, for a total transaction of $472,944.64. Following the sale, the director now owns 18,341 shares in the company, valued at approximately $4,840,556.72. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, General Counsel John W. Geelan sold 1,789 shares of the company’s stock in a transaction dated Friday, August 9th. The stock was sold at an average price of $256.73, for a total transaction of $459,289.97. Following the completion of the transaction, the general counsel now owns 15,065 shares of the company’s stock, valued at approximately $3,867,637.45. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 16,276 shares of company stock valued at $3,936,252 in the last quarter. 3.00% of the stock is currently owned by company insiders.
About Piper Sandler Companies
Piper Sandler Companies operates as an investment bank and institutional securities firm that serves corporations, private equity groups, public entities, non-profit entities, and institutional investors in the United States and internationally. It offers investment banking services and institutional sales, trading, and research services for various equity and fixed income products; advisory services, such as mergers and acquisitions, equity and debt private placements, and debt and restructuring advisory; raises capital through equity and debt financings; underwrites municipal issuances; and municipal financial advisory and loan placement services, as well as various over-the-counter derivative products.
Featured Stories
- Five stocks we like better than Piper Sandler Companies
- How to Calculate Return on Investment (ROI)
- Buy the Dip? UiPath Stock’s GenAI Strategy May Pay Off
- How is Compound Interest Calculated?
- Global Lithium Demand Soars: Top 3 Stocks Positioned to Gain
- What is the Nasdaq? Complete Overview with History
- Oil Prices Fall, Sector Pulls Back: Time to Buy this Stock?
Receive News & Ratings for Piper Sandler Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Piper Sandler Companies and related companies with MarketBeat.com's FREE daily email newsletter.